Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:ALXN
Tag: NASDAQ:ALXN
Insider Trading Activity Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) – Director Sold 700...
ME Staff
-
August 2, 2017
0
Analyst Activity – BMO Capital Markets Raises Its Price Target On...
ME Staff
-
July 28, 2017
0
Analyst Upgrades – Alexion Pharmaceuticals (NASDAQ:ALXN) Stock Gets Upgraded By Oppenheimer...
ME Staff
-
July 28, 2017
0
Analyst Upgrades – Alexion Pharmaceuticals (NASDAQ:ALXN) Stock Gets Upgraded By Oppenheimer...
ME Staff
-
July 28, 2017
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) reported earnings of $1.56 per share beating...
ME Staff
-
July 27, 2017
0
ALEXION PHARMACEUTICALS, INC. (NASDAQ:ALXN) Files An 8-K Results of Operations and...
ME Staff 8-k
-
July 27, 2017
0
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Reaches Funding Agreement for Strensiq
Andy Parker
-
July 6, 2017
0
Biotech Movers: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and...
-
June 15, 2017
0
ALEXION PHARMACEUTICALS, INC. (NASDAQ:ALXN) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
June 13, 2017
0
ALEXION PHARMACEUTICALS, INC. (NASDAQ:ALXN) Files An 8-K Departure of Directors or...
ME Staff 8-k
-
May 23, 2017
0
1
...
4
5
6
7
Page 5 of 7
